HSBC Holdings
ONC

HSBC Holdings’s BeOne Medicines Ltd ONC Stock Holding History

HSBC Holdings’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-18,288
Closed -$2.56M – 2927
2018
Q4 		$2.56M Buy
+18,288
New +$2.43M ﹤0.01% 1396

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HSBC Holdings's ONC Position: Q1 2026 in Review

HSBC Holdings reduced its BeOne Medicines Ltd (ONC) stake by 81% in Q1 2026, selling an estimated $967K and leaving 707 shares worth $208K. The position accounts for ﹤0.01% of the portfolio, ranked #2597.

HSBC Holdings first reported a position in ONC in Q3 2016 and has held it in 35 quarters since. The position peaked at $453M in Q3 2018. 282 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • HSBC Holdings held 707 shares of BeOne Medicines Ltd worth $208K as of Q1 2026.
  • HSBC Holdings sold 2,987 BeOne Medicines Ltd shares in Q1 2026, an estimated $967K.
  • BeOne Medicines Ltd made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2597 holding.
  • HSBC Holdings first reported a position in BeOne Medicines Ltd in Q3 2016 and has held it in 35 quarters since.
  • HSBC Holdings's BeOne Medicines Ltd position peaked at $453M in Q3 2018.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.